Arkolith/Insider Trading/IBRX/Form 4

Simon Barry J.

DirectorImmunityBio, Inc. (IBRX) · full profile →Form 4 · filed Jan 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2026Sell(S)75K$7.88$591K3.1M
Jan 20, 2026Sell(S)77K$6.54$503K3.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001647994-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML